Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationTransplantation ConditioningStem CellsHematopoietic Stem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeGraft vs Host DiseaseHematologic NeoplasmsBone Marrow TransplantationMelphalanHematopoietic Stem Cell MobilizationCyclophosphamideAntigens, CD34Graft SurvivalEtoposideTransplantationSalvage TherapyRemission InductionRecurrenceDisease-Free SurvivalTissue DonorsRetrospective StudiesHodgkin DiseaseMyeloablative AgonistsHistocompatibility TestingStem Cell NicheLymphoma, Non-HodgkinSurvival RateAdult Stem CellsGranulocyte Colony-Stimulating FactorEmbryonic Stem CellsImmunocompromised HostWhole-Body IrradiationSurvival AnalysisCytarabineCell DifferentiationTransplantation ChimeraBone Marrow PurgingImmunosuppressive AgentsBusulfanCarmustineMesenchymal Stem Cell TransplantationFollow-Up StudiesHepatic Veno-Occlusive DiseaseTime FactorsHematopoiesisThiotepaAmyloidosisVincristineKidney TransplantationLeukemiaPrognosisPluripotent Stem CellsBoronic AcidsPyrazinesCytomegalovirus InfectionsLymphoma, Mantle-CellDexamethasoneAntibodies, Monoclonal, Murine-DerivedDoxorubicinAntineoplastic AgentsCell LineageLymphoma, FollicularThalidomideCord Blood Stem Cell TransplantationBone Marrow CellsLymphoma, T-Cell, PeripheralHistocompatibilityNeural Stem CellsFlow CytometryCells, CulturedBone MarrowInduced Pluripotent Stem CellsLeukemia, Myeloid, AcuteLymphomaAntineoplastic Agents, AlkylatingAnemia, AplasticMesenchymal Stromal CellsMice, Inbred C57BLLeukapheresisOpportunistic InfectionsHLA AntigensCell TransplantationAutograftsFatal OutcomeLiver TransplantationIfosfamideMultipotent Stem CellsProspective StudiesFetal BloodCell ProliferationGraft RejectionInduction ChemotherapyMyelodysplastic Syndromes